Speaker

Markus Gruber

Head IP Solid Tumors and Radioligand Therapies - Novartis

Markus Gruber, Head IP Solid Tumors and Radioligand Therapies - Novartis, spoke at Life Science Legal Strategy Summit 2026 (Frankfurt, Germany, 13–14 Oct 2026) in the session “Second Medical Use and Skinny Labelling: Building a Robust IP and Exclusivity Strategy”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

Life Science Legal Strategy Summit 2026
13–14 Oct 2026Frankfurt, Germany
- SpeakerSecond Medical Use and Skinny Labelling: Building a Robust IP and Exclusivity StrategyWith Anna Wolters-Hohne, Corinna Sundermann, Eduardo Hallak, Stefania Bergia, Dexter Whitley

More speakers at Life Science Legal Strategy Summit 2026

Rob Rodrigues
Partner, Partner - RNA Law
Amalia Athanasiadou
Lead Counsel Antitrust - CSL Vifor
Laila Beynon
Director, Dispute Resolution - Regeneron
Joshua Bleet
Executive VP of International Legal & Regulatory Analysis - IPD Analytics
Florian Brandt
Senior Director Legal & Regulatory Europe - IPD Analytics
Tamaris Bucher
Principal Patent Attorney - Novartis

See all 91 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Markus Gruber, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].